back

1. Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide α-N-acetylgalactosaminyltransferase (pp-GalNAc-T10).   

 Kubota T, Shiba T, Sugioka S, Furukawa S, Sawaki H, Kato R, Wakatsuki S, Narimatsu H.

J Mol Biol, 359(3): 708-27 (2006).

 

2. Strategy for the fine characterization of glycosyltransferase specificity using isotopomer assembly.

 Ito H, Kameyama A, Sato T, Sukegawa M, Ishida HK, Narimatsu H.  

Nat Methods. 4(7):577-82 .(2007).

 

3. Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activation. 

 Togayachi A, Kozono Y, Ishida H, Abe S, Suzuki N, Tsunoda Y, Hagiwara K, Kuno A, Ohkura T, Sato N, Sato T, Hirabayashi J, Ikehara Y, Tachibana K, Narimatsu H.

Proc Natl Acad Sci U S A. 104(40):15829-34. (2007).

 

4. Engineering of mucin-type human glycoproteins in yeast cells. 

 Amano K, Chiba Y, Kasahara Y, Kato Y, Kaneko MK, Kuno A, Ito H, Kobayashi K, Hirabayashi J, Jigami Y, Narimatsu H.

Proc Natl Acad Sci U S A. 105(9):3232-7. (2008).

 

5.  Strategy for glycoproteomics: Identification of glyco-alteration using multiple glycan profiling tools.

 Ito H, Kuno A, Sawaki H, Sogabe M, Ozaki H, Tanaka Y, Mizokami M, Shoda JI, Angata T, Sato T, Hirabayashi J, Ikehara Y, Narimatsu H.  

J Proteome Res.  8(3) : 1358-1367. (2009).

 

6. Lack of lacto/neolacto-glycolipids enhances the formation of glycolipid-enriched microdomains, facilitating B cell activation. 

 Togayachi A, Kozono Y, Ikehara Y, Ito H, Suzuki N, Tsunoda Y, Abe S, Sato T, Nakamura K, Suzuki M, Goda HM, Ito M, Kudo T, Takahashi S, Narimatsu H.

Proc Natl Acad Sci U S A. 107(26):11900-5.  

 

7. Wisteria floribunda agglutinin-positive MUC1 is a sensitive biliary marker for human cholangiocarcinoma. 

 Matsuda A, Kuno A, Kawamoto T, Matsuzaki H, Irimura T, Ikehara Y, Zen Y, Nakanuma Y , Yamamoto M, Ohkohchi N, Shoda J, Hirabayashi J, Narimatsu H.

Hepatology  52(1):174-82.

 

8. LecT-Hepa: A triplex lectin-antibody sandwich immunoassay for estimating the progression dynamics of liver fibrosis assisted by a bedside clinical chemistry analyzer and an automated pretreatment machine.

 Kuno A, Ikehara Y, Tanaka Y, Saito K, Ito K, Tsuruno C, Nagai S, Takahama Y, Mizokami M, Hirabayashi J, Narimatsu H.  

Clin Chim Acta. 12(19-20):1767-72. 

 

9. LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.

 Ito K, Kuno A, Ikehara Y, Sugiyama M, Saito H, Aoki Y, Matsui T, Imamura M, Korenaga M, Murata K, Masaki N, Tanaka Y, Hige S, Izumi N, Kurosaki M, Nishiguchi S, Sakamoto M, Kage M, Narimatsu H, Mizokami M.  

Hepatology. 56(4):1448-56 

 

10. Large-scale identification of target proteins of a glycosyltransferase isozyme by Lectin-IGOT-LC/MS, an LC/MS-based glycoproteomic approach. 

 Sugahara D, Kaji H, Sugihara K, Asano M, Narimatsu H.

Sci Rep. 2:680.（2012Sep）